Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers).

× No keyword cloud information.

22 in total

1. Factor VIII inhibitor and source of replacement therapy.

Authors: Pier Mannuccio Mannucci; Alessandro Gringeri; Elena Santagostino; Flora Peyvandi
Journal: Blood Transfus Date: 2011-09-21 Impact factor: 3.443

2. Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better.

Authors: Pier Mannuccio Mannucci
Journal: Blood Transfus Date: 2010-10 Impact factor: 3.443

3. Cost-utility analysis of factor VIII diet therapies prepared using blood plasma vs. recombinant technique for patients with hemophilia A.

Authors: Farhad Lotfi; Hamid Talebianpour; Khosro Keshavarz; Fatemeh Emadi; Mohammad Reza Bordbar; Peivand Bastani
Journal: Daru Date: 2020-04-22 Impact factor: 3.117

Review 4. Clinical use of factor VIII and factor IX concentrates.

Authors: Massimo Morfini; Antonio Coppola; Massimo Franchini; Giovanni Di Minno
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 5. Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors: Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 6. Present and future challanges in the treatment of haemophilia: a clinician's perspective.

Authors: Pier Mannuccio Mannucci; Massimo Franchini
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 7. Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?

Authors: Vincenzo De Angelis; Antonio Breda
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

8. Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors: Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal: Blood Transfus Date: 2014-10 Impact factor: 3.443

9. Factor VIII inhibitors in hemophilia A: rationale and latest evidence.

Authors: Char Witmer; Guy Young
Journal: Ther Adv Hematol Date: 2013-02

Review 10. Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.

Authors: Zera Tellier; Marie-Hélène André; Benoît Polack
Journal: Clin Rev Allergy Immunol Date: 2009-10 Impact factor: 8.667